Nuclear Medicine / Radiopharmaceuticals Market Worth $5.26 Billion by 2023 : Leading Companies Are Cardinal Health, GE Healthcare, Curium, and Lantheus Medical Imaging
MarketsandMarkets forecasts the nuclear medicine market is expected to reach USD 5.2 billion by 2024 from an estimated USD 4.1 billion in 2019, growing at a CAGR of 4.7%.
View full press release